SE445215B - 4-hydroxi-3-metoxi-n-(2-(2-(1-metyl-2-piperidinyl)etyl)fenyl)bensamid,forfarande for framstellning av denna, samt en farmaceutisk komposition med antiarytmisk aktivitet - Google Patents
4-hydroxi-3-metoxi-n-(2-(2-(1-metyl-2-piperidinyl)etyl)fenyl)bensamid,forfarande for framstellning av denna, samt en farmaceutisk komposition med antiarytmisk aktivitetInfo
- Publication number
- SE445215B SE445215B SE8105538A SE8105538A SE445215B SE 445215 B SE445215 B SE 445215B SE 8105538 A SE8105538 A SE 8105538A SE 8105538 A SE8105538 A SE 8105538A SE 445215 B SE445215 B SE 445215B
- Authority
- SE
- Sweden
- Prior art keywords
- compound
- ethyl
- benzamide
- piperidinyl
- hydroxy
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/188,184 US4332803A (en) | 1980-09-18 | 1980-09-18 | Benzanilide derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8105538L SE8105538L (sv) | 1982-03-19 |
SE445215B true SE445215B (sv) | 1986-06-09 |
Family
ID=22692080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8105538A SE445215B (sv) | 1980-09-18 | 1981-09-18 | 4-hydroxi-3-metoxi-n-(2-(2-(1-metyl-2-piperidinyl)etyl)fenyl)bensamid,forfarande for framstellning av denna, samt en farmaceutisk komposition med antiarytmisk aktivitet |
Country Status (25)
Country | Link |
---|---|
US (1) | US4332803A (xx) |
JP (1) | JPS5782368A (xx) |
AR (1) | AR227065A1 (xx) |
AT (1) | AT378181B (xx) |
AU (1) | AU526825B2 (xx) |
BE (1) | BE890418A (xx) |
CA (1) | CA1183537A (xx) |
CH (2) | CH651932A5 (xx) |
CY (2) | CY1370A (xx) |
DE (2) | DE3137084C2 (xx) |
DK (1) | DK152121C (xx) |
FI (1) | FI66597C (xx) |
FR (1) | FR2494267B1 (xx) |
GB (2) | GB2084570B (xx) |
GR (1) | GR75788B (xx) |
HK (2) | HK5388A (xx) |
IE (1) | IE51584B1 (xx) |
IT (1) | IT1209900B (xx) |
KE (2) | KE3717A (xx) |
LU (1) | LU83644A1 (xx) |
NL (1) | NL8104261A (xx) |
SE (1) | SE445215B (xx) |
SG (1) | SG30187G (xx) |
YU (1) | YU42425B (xx) |
ZA (1) | ZA816348B (xx) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4618680A (en) * | 1980-09-18 | 1986-10-21 | Mead Johnson & Company | Benzanilide derivative |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA961038A (en) * | 1971-03-03 | 1975-01-14 | Joseph L. Minielli | Substituted piperidines |
US3931195A (en) * | 1971-03-03 | 1976-01-06 | Mead Johnson & Company | Substituted piperidines |
-
1980
- 1980-09-18 US US06/188,184 patent/US4332803A/en not_active Expired - Lifetime
-
1981
- 1981-09-08 GB GB8127079A patent/GB2084570B/en not_active Expired
- 1981-09-08 CY CY137081A patent/CY1370A/xx unknown
- 1981-09-11 AU AU75181/81A patent/AU526825B2/en not_active Ceased
- 1981-09-11 YU YU2192/81A patent/YU42425B/xx unknown
- 1981-09-14 ZA ZA816348A patent/ZA816348B/xx unknown
- 1981-09-15 FI FI812873A patent/FI66597C/fi not_active IP Right Cessation
- 1981-09-15 FR FR8117391A patent/FR2494267B1/fr not_active Expired
- 1981-09-15 NL NL8104261A patent/NL8104261A/nl not_active Application Discontinuation
- 1981-09-16 DK DK412881A patent/DK152121C/da not_active IP Right Cessation
- 1981-09-17 CH CH90/85A patent/CH651932A5/de not_active IP Right Cessation
- 1981-09-17 CH CH6017/81A patent/CH650497A5/de not_active IP Right Cessation
- 1981-09-17 IT IT8149311A patent/IT1209900B/it active
- 1981-09-17 DE DE3137084A patent/DE3137084C2/de not_active Expired
- 1981-09-17 GR GR66079A patent/GR75788B/el unknown
- 1981-09-17 IE IE2160/81A patent/IE51584B1/en not_active IP Right Cessation
- 1981-09-17 DE DE3153300A patent/DE3153300C2/de not_active Expired
- 1981-09-18 AR AR286799A patent/AR227065A1/es active
- 1981-09-18 LU LU83644A patent/LU83644A1/fr unknown
- 1981-09-18 CA CA000386216A patent/CA1183537A/en not_active Expired
- 1981-09-18 BE BE0/206007A patent/BE890418A/fr not_active IP Right Cessation
- 1981-09-18 AT AT0403781A patent/AT378181B/de active
- 1981-09-18 SE SE8105538A patent/SE445215B/sv not_active IP Right Cessation
- 1981-09-18 JP JP56146406A patent/JPS5782368A/ja active Granted
-
1984
- 1984-02-02 GB GB08402839A patent/GB2144050B/en not_active Expired
- 1984-02-02 CY CY137784A patent/CY1377A/xx unknown
-
1987
- 1987-03-27 SG SG301/87A patent/SG30187G/en unknown
- 1987-03-31 KE KE3717A patent/KE3717A/xx unknown
- 1987-03-31 KE KE3716A patent/KE3716A/xx unknown
-
1988
- 1988-01-21 HK HK53/88A patent/HK5388A/xx unknown
- 1988-01-21 HK HK44/88A patent/HK4488A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0244080A2 (en) | Medicament for the treatment of obesity | |
US20040043083A1 (en) | Anticancer composition comprising sesquiterpenes isolated from resina ferulae | |
US4083968A (en) | Therapeutic agent for improving cardiovascular function | |
JPS6322082A (ja) | 1―(ヒドロキシスチリル)―5h―2,3―ベンゾジアゼピン誘導体およびその製造方法、並びに前記誘導体を含む薬剤 | |
EP0085870B1 (en) | Dibenz(b,e)oxepin derivatives and pharmaceutical compositions containing them | |
SE445215B (sv) | 4-hydroxi-3-metoxi-n-(2-(2-(1-metyl-2-piperidinyl)etyl)fenyl)bensamid,forfarande for framstellning av denna, samt en farmaceutisk komposition med antiarytmisk aktivitet | |
EP0448029B1 (en) | Novel pharmaceutical uses of forskolin derivatives | |
EP0074411B1 (en) | Ascorbic acid derivatives | |
KR100407849B1 (ko) | 헬리코박터의감염에기인하는질환의치료제 | |
US5362726A (en) | Compound and method of treatment for falciparum malaria | |
US4618680A (en) | Benzanilide derivative | |
US20050014751A1 (en) | Use of n-acyl homoserine lactones for the treatment of insulitis | |
JPS63135378A (ja) | ブチロラクトン誘導体、その製造方法およびその用途 | |
JPH032183A (ja) | ビスベンジルイソキノリン誘導体 | |
EP1621196A1 (en) | Therapeutic and/or preventive agent for chronic skin disease | |
JP2860385B2 (ja) | ビスべンジルイソキノリン誘導体 | |
JPH0723358B2 (ja) | ピロールの新規アロイル誘導体 | |
JPS6112624A (ja) | 抗高血圧剤 | |
JP2694321B2 (ja) | インターロイキン−1阻害剤 | |
RU2228753C2 (ru) | Изоникотиноилгидразид фталевой кислоты, проявляющий гипогликемическую активность | |
JPH0368578A (ja) | ビスベンジルイソキノリン誘導体 | |
JP3949197B2 (ja) | Mrsa感染防御剤 | |
NO152750B (no) | Fremgangsmaate for fremstilling av nitrogen brohode-kondenserte pyrimidinforbindelser | |
EP0343832A2 (en) | 5H-pyrazolo(4,3-a)quinolizin-5-one compounds exhibiting therapeutic activities | |
RU2183625C2 (ru) | Изоникотиноилгидразид цитраконовой кислоты, проявляющий гипогликемическую активность |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8105538-6 Effective date: 19940410 Format of ref document f/p: F |